èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã VistaGen Therapeutics, Inc. ã¯ãäžå®ããã€ç
ããã®ä»ã®äžæ¢ç¥çµç³» (CNS) éå®³ã®æ²»çã«ã€ãªããå¯èœæ§ã®ããããŸããŸãªå»è¬åã®éçºãšåååã«åãçµãã§ããŸããå瀟㮠CNS ãã€ãã©ã€ã³ã«ã¯ã瀟äŒäžå®éå®³ãæ£ãæäººã®æ¥æ§äžå®çã®æ²»çè¬ãšããŠç¬¬ III çžéçºæºåäžã®å³å¹æ§ç¥çµæŽ»æ§ç¹éŒ»è¬ PH94B ãå«ãŸããŠããŸãããŸããPH94B 補åã¯ãäžå®çã䌎ãé©å¿é害ãç£åŸäžå®çãå¿çå€å·åŸã¹ãã¬ã¹é害ãæè¡åäžå®çããããã¯çãªã©ãããŸããŸãªäžå®çã®æ²»çè¬ãšããŠã®å¯èœæ§ãç§ããŠããŸããå瀟㮠CNS ãã€ãã©ã€ã³ã«ã¯ã倧ãã€ç
æ§é害 (MDD) ã®åç¬æ²»çè¬ãšããŠç¬¬ IIB çžèšåºéçºæºåäžã®å³å¹æ§ç¥çµæŽ»æ§ç¹éŒ»è¬ PH10 ãå«ãŸããŠããŸãã AV-101 ã¯çµå£ N-ã¡ãã«-D-ã¢ã¹ãã©ã®ã³é
žåå®¹äœæ®æè¬ã§ãããããã·ããšã®äœµçšã§ãã¬ãããèªçºæ§ãžã¹ãããžã¢ãMDDãç¥çµé害æ§çŒçãèªæ®ºå¿µæ
®ã®æœåšçæ²»çè¬ãšããŠéçºäžã§ããå瀟㯠Cato Research Ltd. ãšå¥çŽç ç©¶éçºå¥çŽããPherin Pharmaceuticals, Inc. ãšã©ã€ã»ã³ã¹ããã³ãªãã·ã§ã³å¥çŽããEverInsight Therapeutics Inc. ãšã©ã€ã»ã³ã¹ããã³ååå¥çŽããBlueRock Therapeutics, LP ãšã©ã€ã»ã³ã¹ããã³ãµãã©ã€ã»ã³ã¹å¥çŽãç· çµããŠããŸããå瀟㯠1998 幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµãŠã¹ãµã³ãã©ã³ã·ã¹ã³ã«æ¬ç€Ÿã眮ããŠããŸãã